This new 249-page report from Venture Planning Group provides a comprehensive analysis of the US therapeutic drug monitoring market, including emerging tests, technologies, instrumentation, sales forecasts, market shares, and strategic profiles of leading suppliers.
The report provides test volume and sales forecasts by country and market segment for the following assays: Amikacin, Carbamazepine, Cyclosporin, Digoxin, Everolimus, Gentamicin, Levetiracetam, Lithium, Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid and Vancomycin.
During the next five years, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.
2014 Strategies for the US Therapeutic Drug Monitoring (TDM) Market? is a unique market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.
Contains 249 pages and 19 tables
SIMILAR MARKET STUDIES
?New Frontiers in the UK Automated Microbiology Market: Business Challenges, Emerging Technologies, Competitive Landscape? is Venture Planning Group?s new analysis of the major business opportunities emerging in the automated microbiology market during the next five years. The report examines key trends in the UK automated microbiology market; reviews current ...
May 2014 | $4500 | View Details >>
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next ten years, the worldwide cancer testing market is promising ...
June 2016 | $0 | View Details >>
2016 Future Horizons and Growth Strategies in the UK Respiratory Diseases Diagnostic Testing Market: Supplier Shares by Test, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities
About This ReportThis new 281-page report from VPGMarketResearch.com presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV and Tuberculosis. The report provides test volume and sales projections for Hospitals, Commercial and Public Health Labs.In addition to ...
November 2015 | $1250 | View Details >>
This new report from VPGMarketResearch.com provides strategic assessment of Hologics technological know-how, marketing tactics and strategic directions in the global diagnostic imaging market.
January 2015 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research